A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer

NCT07455422 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

266

Enrollment

OTHER

Sponsor class

Conditions

Barrett Esophagus
Barrett Esophagus Adenocarcinoma
Adenocarcinoma - GEJ
Gastroenterology
Gastroenterological Cancer

Interventions

OTHER: Risk profile disclosure

Sponsor

University Hospital, Antwerp

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]